Golden has been acquired by ComplyAdvantage.Read about it here ⟶

‌

US Patent RE44596 Method for the detection of cancer

Patent RE44596 was granted and assigned to Guardant Health on November, 2013 by the United States Patent and Trademark Office.

Overview Structured Data Issues Contributors Activity

Is a

Patent

Patent attributes

Current Assignee

Guardant Health

Patent Jurisdiction

United States Patent and Trademark Office

Patent Number

RE445960

Date of Patent

November 12, 2013

Patent Application Number

134471040

Date Filed

April 13, 2012

Patent Citations Received

‌

US Patent 12094573 Methods for multi-resolution analysis of cell-free nucleic acids

‌

US Patent RE49542 Method for the detection of cancer

‌

US Patent 11674168 Isolation and detection of DNA from plasma

‌

US Patent 11692218 Spatial transcriptomics for antigen-receptors

‌

US Patent 11753674 Methods and systems for determining spatial patterns of biological targets in a sample

...

Patent Primary Examiner

‌

Eileen B O Hara

No article content yet.

Timeline

No Timeline data yet.

Further Resources

Title

Author

Link

Type

Date

No Further Resources data yet.

References

Find more entities like US Patent RE44596 Method for the detection of cancer

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.

Open Query Tool

Access by API